- Home /
- CP Reports /
- Deal type reports
Deal type reports
-
Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2019
$2,995.00Publication date: Apr 2019 | Publisher: Current Partnering
The Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2019 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019
$2,995.00Publication date: Apr 2019 | Publisher: Current Partnering
The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 report provides comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the worlds leading biopharma companies.
Learn More -
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019
$2,995.00Publication date: Apr 2019 | Publisher: Current Partnering
The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies Learn More -
Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2019
$2,995.00Publication date: Apr 2019 | Publisher: Current Partnering
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2019 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.
Learn More -
Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2014-2019
$2,995.00Publication date: Apr 2019 | Publisher: Current Partnering
The Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2014-2019 report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies.
Learn More -
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2019
$2,995.00Publication date: Apr 2019 | Publisher: Current Partnering
The Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2019 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies
Learn More -
Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2019
$2,995.00Publication date: Apr 2019 | Publisher: Current Partnering
The Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2019 report provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2019
$2,995.00Publication date: Apr 2019 | Publisher: Current Partnering
The Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2019 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019
$2,995.00Publication date: Apr 2019 | Publisher: Current Partnering
The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2014-2019
$2,995.00Publication date: Apr 2019 | Publisher: Current Partnering
Essential Benchmark Data for Dealmakers - The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2014-2019 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments.
Learn More
